(FY)Jun 30, 2024 | (FY)Jun 30, 2023 | |
---|---|---|
Operating cash flow (direct method) | ||
Cash income from operating activities | ||
Cash paid | -4.04%-1.28M | -1.23M |
Payments to suppliers for goods and services | -4.04%-1.28M | ---1.23M |
Direct interest received | -3.75%145.2K | --150.86K |
Operating cash flow | -5.12%-1.14M | ---1.08M |
Investing cash flow | ||
Cash flow from continuing investing activities | -64.77%-4.71M | -2.86M |
Capital expenditure reported | -54.92%-4.42M | ---2.85M |
Net PPE purchase and sale | 43.66%-4.19K | ---7.43K |
Net investment purchase and sale | ---289.03K | ---- |
Cash from discontinued investing activities | ||
Investing cash flow | -64.77%-4.71M | ---2.86M |
Financing cash flow | ||
Cash flow from continuing financing activities | -63.03%3.12M | 8.43M |
Net common stock issuance | -63.03%3.12M | --8.43M |
Cash from discontinued financing activities | ||
Financing cash flow | -63.03%3.12M | --8.43M |
Net cash flow | ||
Beginning cash position | 620.57%5.21M | --722.87K |
Current changes in cash | -160.94%-2.73M | --4.49M |
Effect of exchange rate changes | --5.46K | ---- |
End cash Position | -52.37%2.48M | --5.21M |
Free cash from | -41.07%-5.56M | ---3.94M |
Accounting Standards | US-GAAP | US-GAAP |
No Data
No Data